Compare Procter & Gamble Health with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs ABBOTT INDIA - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH ABBOTT INDIA PROCTER & GAMBLE HEALTH/
ABBOTT INDIA
 
P/E (TTM) x 42.8 56.4 75.9% View Chart
P/BV x 4.6 16.6 27.5% View Chart
Dividend Yield % 10.4 0.4 2,509.5%  

Financials

 PROCTER & GAMBLE HEALTH   ABBOTT INDIA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
ABBOTT INDIA
Mar-19
PROCTER & GAMBLE HEALTH/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs3,5498,834 40.2%   
Low Rs1,3015,458 23.8%   
Sales per share (Unadj.) Rs511.41,731.1 29.5%  
Earnings per share (Unadj.) Rs61.3211.9 28.9%  
Cash flow per share (Unadj.) Rs74.0219.9 33.7%  
Dividends per share (Unadj.) Rs440.0065.00 676.9%  
Dividend yield (eoy) %18.10.9 1,994.6%  
Book value per share (Unadj.) Rs927.8945.2 98.2%  
Shares outstanding (eoy) m16.6021.25 78.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.74.1 114.9%   
Avg P/E ratio x39.633.7 117.3%  
P/CF ratio (eoy) x32.832.5 100.8%  
Price / Book Value ratio x2.67.6 34.6%  
Dividend payout %717.930.7 2,340.6%   
Avg Mkt Cap Rs m40,257151,848 26.5%   
No. of employees `0001.13.5 32.5%   
Total wages/salary Rs m1,3134,356 30.1%   
Avg. sales/employee Rs Th7,486.710,555.5 70.9%   
Avg. wages/employee Rs Th1,157.61,249.9 92.6%   
Avg. net profit/employee Rs Th897.21,292.2 69.4%   
INCOME DATA
Net Sales Rs m8,49036,786 23.1%  
Other income Rs m2441,133 21.5%   
Total revenues Rs m8,73437,919 23.0%   
Gross profit Rs m1,4826,047 24.5%  
Depreciation Rs m211169 124.8%   
Interest Rs m023 0.0%   
Profit before tax Rs m1,5146,989 21.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m660-   
Tax Rs m5632,485 22.6%   
Profit after tax Rs m1,0174,503 22.6%  
Gross profit margin %17.516.4 106.2%  
Effective tax rate %37.135.6 104.5%   
Net profit margin %12.012.2 97.9%  
BALANCE SHEET DATA
Current assets Rs m15,34327,610 55.6%   
Current liabilities Rs m1,9608,569 22.9%   
Net working cap to sales %157.651.8 304.5%  
Current ratio x7.83.2 242.9%  
Inventory Days Days4960 80.9%  
Debtors Days Days2827 103.8%  
Net fixed assets Rs m1,2091,057 114.4%   
Share capital Rs m166213 78.1%   
"Free" reserves Rs m15,23519,873 76.7%   
Net worth Rs m15,40120,086 76.7%   
Long term debt Rs m00-   
Total assets Rs m17,59529,409 59.8%  
Interest coverage xNM311.6-  
Debt to equity ratio x00-  
Sales to assets ratio x0.51.3 38.6%   
Return on assets %5.815.4 37.6%  
Return on equity %6.622.4 29.5%  
Return on capital %10.334.9 29.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,636369 443.5%   
Fx outflow Rs m4,3684,918 88.8%   
Net fx Rs m-2,732-4,549 60.0%   
CASH FLOW
From Operations Rs m-1,3044,991 -26.1%  
From Investments Rs m12,697-2,570 -494.1%  
From Financial Activity Rs m-301-1,428 21.0%  
Net Cashflow Rs m11,093993 1,116.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 75.0 69.1%  
Indian inst/Mut Fund % 18.2 7.9 230.4%  
FIIs % 1.0 0.1 1,000.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 17.1 170.2%  
Shareholders   28,591 18,270 156.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   STERLING BIOTECH  PFIZER  ALEMBIC PHARMA  SHASUN PHARMA  SANOFI INDIA  

Compare PROCTER & GAMBLE HEALTH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 466 Points Higher; Energy, Auto and Realty Stocks Rally(Closing)

Indian share markets extended gains as the session progressed and ended on a strong note, driven by automobile stocks and index heavyweight Reliance Industries.

Related Views on News

PROCTER & GAMBLE HEALTH Share Price Up by 5%; BSE HEALTHCARE Index Down 0.2% (Market Updates)

Jul 6, 2020 | Updated on Jul 6, 2020

PROCTER & GAMBLE HEALTH share price is trading up by 5% and its current market price is Rs 4,311. The BSE HEALTHCARE is down by 0.2%. The top gainers in the BSE HEALTHCARE Index are PROCTER & GAMBLE HEALTH (up 5.1%) and DISHMAN CARBOGEN AMCIS LTD (up 7.9%). The top losers are GRANULES INDIA and STRIDES PHARMA SCIENCE (down 0.3%).

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Jul 6, 2020 03:33 PM

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - PFIZER COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS